Resolvin D1 and D2 Reverse Lipopolysaccharide-Induced Depression-Like Behaviors Through the mTORC1 Signaling Pathway

International Journal of Neuropsychopharmacology

Volumn 20, Issue 7, 2017, Pages 575-584

  Deyama, Satoshi ^a,b   Ishikawa, Yuka ^a   Yoshikawa, Kotomi ^a   Shimoda, Kento ^a   Ide, Soichiro ^a,c   Satoh, Masamichi ^d   Minami, Masabumi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Dentate gyrus; Depression; Medial prefrontal cortex; mTORC1; Resolvin

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; ANTIDEPRESSANT AGENT; LIPOPOLYSACCHARIDE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; RESOLVIN D1; RESOLVIN D2; UNCLASSIFIED DRUG; DOCOSAHEXAENOIC ACID; OLIGOPEPTIDE; TRYPTOPHYL-ARGINYL-TRYPTOPHYL-TRYPTOPHYL-TRYPTOPHYL-TRYPTOPHANAMIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; LOCOMOTION; MALE; MEDIAL PREFRONTAL CORTEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SIGNAL TRANSDUCTION; TAIL SUSPENSION TEST; ANIMAL; BAGG ALBINO MOUSE; BRAIN; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECT; IMMOBILIZATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; NONPARAMETRIC TEST; PROCEDURES; TONIC IMMOBILITY;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSION; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; HINDLIMB SUSPENSION; IMMOBILITY RESPONSE, TONIC; INJECTIONS, INTRAVENTRICULAR; LIPOPOLYSACCHARIDES; LOCOMOTION; MALE; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MICE; MICE, INBRED BALB C; OLIGOPEPTIDES; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC;

EID: 85024104207     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyx023     Document Type: Article

References (31)

1. Aguilar-Valles A, Kim J, Jung S, Woodside B, Luheshi GN (2014) Role of brain transmigrating neutrophils in depressionlike behavior during systemic infection. Mol Psychiatry 19:599-606.
2. Chiang N, Dalli J, Colas RA, Serhan CN (2015) Identification of resolvin D2 receptor mediating resolution of infections and organ protection. J Exp Med 212:1203-1217.
3. Duman RS, Aghajanian GK, Sanacora G, Krystal JH (2016) Synaptic plasticity and depression: New insights from stress and rapid-acting antidepressants. Nat Med 22:238-249.
4. Ellis JS, Zarate CA Jr, Luckenbaugh DA, Furey ML (2014) Antidepressant treatment history as a predictor of response to scopolamine: Clinical implications. J Affect Disord 162:39-42.
5. Franklin KBJ, Paxinos G (2007) The mouse brain in stereotaxic coordinates, 3rd ed. Burlington, MA: Elsevier.
6. Gilbert K, Bernier J, Godbout R, Rousseau G (2014) Resolvin D1, a metabolite of omega-3 polyunsaturated fatty acid, decreases post-myocardial infarct depression. Marine drugs 12:5396-5407.
7. Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC (2015) The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry 76:155-162.
8. Haitina T, Fredriksson R, Foord SM, Schioth HB, Gloriam DE (2009) The G protein-coupled receptor subset of the dog genome is more similar to that in humans than rodents. BMC Genomics 10:24.
9. He H, Geng T, Chen P, Wang M, Hu J, Kang L, Song W, Tang H (2016) NK cells promote neutrophil recruitment in the brain during sepsis-induced neuroinflammation. Sci Rep 6:27711.
10. Hodges RR, Li D, Shatos MA, Bair JA, Lippestad M, Serhan CN, Dartt DA (2017) Lipoxin A4 activates ALX/FPR2 receptor to regulate conjunctival goblet cell secretion. Mucosal Immunol 10:46-57.
11. Ji RR, Xu ZZ, Strichartz G, Serhan CN (2011) Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci 34:599-609.
12. Kang A, Hao H, Zheng X, Liang Y, Xie Y, Xie T, Dai C, Zhao Q, Wu X, Xie L, Wang G (2011) Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy. J Neuroinflammation 8:100.
13. Klein CP, Sperotto ND, Maciel IS, Leite CE, Souza AH, Campos MM (2014) Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice. Neuropharmacology 86:57-66.
14. Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, Petasis NA, Serhan CN (2010) Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci USA 107:1660-1665.
15. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329:959-964.
16. Maeng S, Zarate CA Jr, Du J, Schloesser RJ, McCammon J, Chen G, Manji HK (2008) Cellular mechanisms underlying the antidepressant effects of ketamine: Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 63:349-352.
17. Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921-2927.
18. O'Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N, Kelley KW, Dantzer R (2009) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14:511-522.
19. Odusanwo O, Chinthamani S, McCall A, Duffey ME, Baker OJ (2012) Resolvin D1 prevents TNF-alpha-mediated disruption of salivary epithelial formation. Am J Physiol Cell Physiol 302:C1331-1345.
20. Osborn M, Rustom N, Clarke M, Litteljohn D, Rudyk C, Anisman H, Hayley S (2013) Antidepressant-like effects of erythropoietin: A focus on behavioural and hippocampal processes. PLoS One 8:e72813.
21. Pascoal LB, Bombassaro B, Ramalho AF, Coope A, Moura RF, Correa-da-Silva F, Ignacio-Souza L, Razolli D, de Oliveira D, Catharino R, Velloso LA (2017) Resolvin RvD2 reduces hypothalamic inflammation and rescues mice from diet-induced obesity. J Neuroinflammation 14:5.
22. Penumarti A, Abdel-Rahman AA (2014) Neuronal nitric oxide synthase-dependent elevation in adiponectin in the rostral ventrolateral medulla underlies g protein-coupled receptor 18-mediated hypotension in conscious rats. J Pharmacol Exp Ther 351:44-53.
23. Serhan CN (2014) Pro-resolving lipid mediators are leads for resolution physiology. Nature 510:92-101.
24. Shalini SM, Ho CF, Ng YK, Tong JX, Ong ES, Herr DR, Dawe GS, Ong WY (2017) Distribution of Alox15 in the rat brain and its role in prefrontal cortical resolvin D1 formation and spatial working memory. Mol Neurobiol. In press.
25. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M, Team SDS (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR∗D: Implications for clinical practice. Am J Psychiatry 163:28-40.
26. Voleti B, Navarria A, Liu RJ, Banasr M, Li N, Terwilliger R, Sanacora G, Eid T, Aghajanian G, Duman RS (2013) Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses. Biol Psychiatry 74:742-749.
27. Warner-Schmidt JL, Duman RS (2006) Hippocampal neurogenesis: Opposing effects of stress and antidepressant treatment. Hippocampus 16:239-249.
28. Wohleb ES, Franklin T, Iwata M, Duman RS (2016a) Integrating neuroimmune systems in the neurobiology of depression. Nat Rev Neurosci 17:497-511.
29. Wohleb ES, Wu M, Gerhard DM, Taylor SR, Picciotto MR, Alreja M, Duman RS (2016b) GABA interneurons mediate the rapid antidepressant-like effects of scopolamine. J Clin Invest 126:2482-2494.
30. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatmentresistant major depression. Arch Gen Psychiatry 63:856-864.
31. Zeni AL, Zomkowski AD, Maraschin M, Rodrigues AL, Tasca CI (2012) Involvement of PKA, CaMKII, PKC, MAPK/ERK and PI3K in the acute antidepressant-like effect of ferulic acid in the tail suspension test. Pharmacol Biochem Behav 103:181-186.